Market Overview

Allergan Gets FDA Acceptance Of Premarket Notification Filing For XEN Glaucoma Treatment System

Share:

Allergan plc (NYSE: AGN) revealed Wednesday that the 510(k) Premarket Notification Application for its XEN Glaucoma Treatment System, which consisted of the XEN45 Gel Stent and the XEN Injector, was accepted for filing by the Food and Drug Administration. According to the company, XEN45 is a minimally invasive implantable crosslinked gelatin shunt used to reduce intraocular pressure (IOP) associated with refractory glaucoma.

Allergan said XEN45 is CE marked in the European Union, where it was indicated for the reduction of intraocular pressure in patients with primary open angle glaucoma where earlier medical treatments have not succeeded. It was also licensed for use in Canada, Switzerland, and Turkey.

The company's Chief R&D Officer, David Nicholson, commented, "We are pleased that the FDA has accepted the 510(k) filing for the XEN Glaucoma Treatment System, an excellent complement to Allergan's ongoing portfolio and development programs in this critical treatment area. We look forward to working together with the FDA to bring this treatment to market and, in doing so, offer a potential new option to millions of Americans who suffer from glaucoma."

Posted-In: Biotech News FDA General

 

Related Articles (AGN)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Infinity Pharma At Risk Of AbbVie 'Walking Away'

At Disney World, An Alligator Dragged A 2-Year-Old Into Lagoon